| Field | Row 1 |
|---|---|
| adsh | 0001558370-25-006850 |
| cik | 1633932 |
| name | ESSA PHARMA INC. |
| sic | 2834 |
| countryba | CA |
| stprba | BC |
| cityba | VANCOUVER |
| zipba | V5Z 1K5 |
| bas1 | SUITE 720 |
| bas2 | 999 WEST BROADWAY |
| baph | (778) 331-0962 |
| countryma | CA |
| stprma | BC |
| cityma | VANCOUVER |
| zipma | V5Z 1K5 |
| mas1 | SUITE 720 |
| mas2 | 999 WEST BROADWAY |
| countryinc | CA |
| stprinc | BC |
| ein | 000000000 |
| former | |
| changed | |
| afs | 4-NON |
| wksi | 0 |
| fye | 0930 |
| form | 10-Q |
| period | 20250331 |
| fy | 2025 |
| fp | Q2 |
| filed | 20250508 |
| accepted | 2025-05-08 07:01:00.0 |
| prevrpt | 0 |
| detail | 1 |
| instance | epix-20250331x10q_htm.xml |
| nciks | 1 |
| aciks |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
| name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
| sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
| countryba | The ISO 3166-1 country of the registrant's business address. |
| stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
| cityba | The city of the registrant's business address. |
| zipba | The zip code of the registrant’s business address. |
| bas1 | The first line of the street of the registrant’s business address. |
| bas2 | The second line of the street of the registrant’s business address. |
| baph | The phone number of the registrant’s business address. |
| countryma | The ISO 3166-1 country of the registrant's mailing address. |
| stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
| cityma | The city of the registrant's mailing address. |
| zipma | The zip code of the registrant’s mailing address. |
| mas1 | The first line of the street of the registrant’s mailing address. |
| mas2 | The second line of the street of the registrant’s mailing address. |
| countryinc | The ISO 3166-1 country of incorporation for the registrant. |
| stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
| ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
| former | Most recent former name of the registrant, if any. |
| changed | Date of change from the former name, if any. |
| afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
| wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
| fye | Fiscal Year End Date, rounded to nearest month-end. |
| form | The submission type of the registrant’s filing. |
| period | Balance Sheet Date, rounded to nearest month-end. |
| fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
| fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
| filed | The date of the registrant’s filing with the Commission. |
| accepted | The acceptance date and time of the registrant’s filing with the Commission. |
| prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
| detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
| instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
| nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
| aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
| adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
|---|---|---|---|---|---|---|---|---|---|
| 0001558370-25-006850 | 20240331 | Accretion Amortization Of Discounts And Premiums Investments | 421248.0000 | USD | 2 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20240930 | Assets Current | 127559555.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20250331 | Cash And Cash Equivalents At Carrying Value | 86308345.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20240930 | Common Stock Shares Outstanding | 44388550.0000 | shares | 0 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20240331 | Comprehensive Income Net Of Tax | -8989535.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001558370-25-006850 | 20241231 | Comprehensive Income Net Of Tax | -8766.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001558370-25-006850 | 20250331 | Comprehensive Income Net Of Tax | -6374787.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001558370-25-006850 | 20250331 | Earnings Per Share Diluted | -0.1400 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20240331 | Foreign Currency Transaction Gain Loss Before Tax | 14142.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20240331 | General And Administrative Expense | 6533370.0000 | USD | 2 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20250331 | General And Administrative Expense | 3897235.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20250331 | Increase Decrease In Operating Lease Liability | -64347.0000 | USD | 2 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20250331 | Interest And Other Income | 2155309.0000 | USD | 2 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20240930 | Liabilities | 3506233.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20250331 | Liabilities | 1868916.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20240930 | Liabilities And Stockholders Equity | 128112003.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20250331 | Operating Lease Liability Noncurrent | 154289.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20250331 | Operating Lease Right Of Use Asset | 248017.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20240331 | Operating Lease Right Of Use Asset Amortization Expense | 45212.0000 | USD | 2 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20240331 | Payments To Acquire Short Term Investments | 22291096.0000 | USD | 2 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20240930 | Prepaid Expense Current | 636463.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20240331 | Share Based Compensation | 1936019.0000 | USD | 2 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20250331 | Shares Outstanding | 44388550.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001558370-25-006850 | 20230930 | Stockholders Equity | 145627060.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20230930 | Stockholders Equity | -2120398.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001558370-25-006850 | 20230930 | Stockholders Equity | 49047280.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001558370-25-006850 | 20231231 | Stockholders Equity | 49697447.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001558370-25-006850 | 20240930 | Stockholders Equity | 124605770.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20241231 | Stockholders Equity | 279862420.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001558370-25-006850 | 20250331 | Stockholders Equity | 58684837.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001558370-25-006850 | 20231231 | Stock Issued During Period Value Stock Options Exercised | 163306.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20240331 | Stock Issued During Period Value Stock Options Exercised | -524463.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001558370-25-006850 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 44388550.0000 | shares | 1 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 44237124.0000 | shares | 1 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20250331 | Accounts Payable And Accrued Liabilities Current | 1588715.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20240331 | Accretion Expense | 15867.0000 | USD | 2 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20250331 | Accretion Expense | 15288.0000 | USD | 2 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -17401192.0000 | USD | 2 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20240930 | Common Stock Value | 279862420.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20231231 | Comprehensive Income Net Of Tax | 20124.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001558370-25-006850 | 20240331 | Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 4521.0000 | USD | 2 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20240331 | Investment Income Net | 132068.0000 | USD | 2 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20250331 | Liabilities Current | 1714627.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20250331 | Operating Lease Liability Current | 125912.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20240930 | Operating Lease Right Of Use Asset | 295471.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20240331 | Research And Development Expense | 11554751.0000 | USD | 2 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20250331 | Share Based Compensation | 3874040.0000 | USD | 2 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20241231 | Stockholders Equity | -2072033.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001558370-25-006850 | 20241231 | Stockholders Equity | 57512728.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001558370-25-006850 | 20250331 | Stockholders Equity | -222910898.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001558370-25-006850 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 44388550.0000 | shares | 2 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20231231 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 803418.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001558370-25-006850 | 20250331 | Accretion Amortization Of Discounts And Premiums Investments | 402309.0000 | USD | 2 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20250331 | Accumulated Other Comprehensive Income Loss Net Of Tax | -2089855.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20231231 | Comprehensive Income Net Of Tax | -5944198.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20241231 | Comprehensive Income Net Of Tax | -8531931.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001558370-25-006850 | 20250331 | Comprehensive Income Net Of Tax | -6392609.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20240930 | Deposits Assets Noncurrent | 256977.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20250331 | Earnings Per Share Diluted | -0.3400 | USD | 2 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20240331 | General And Administrative Expense | 4315502.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20240331 | Increase Decrease In Receivables | 80111.0000 | USD | 2 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20240930 | Liabilities Current | 3301027.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20240331 | Net Cash Provided By Used In Financing Activities | 840262.0000 | USD | 2 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20250331 | Net Cash Provided By Used In Operating Activities | -13318653.0000 | USD | 2 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20240331 | Net Income Loss | -8989535.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20240331 | Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | 19375.0000 | USD | 2 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20250331 | Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | -17822.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20250331 | Prepaid Expense Current | 879477.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20250331 | Receivables Net Current | 415514.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20240930 | Retained Earnings Accumulated Deficit | -208004180.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20241231 | Shares Outstanding | 44388550.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001558370-25-006850 | 20231231 | Stockholders Equity | -185425681.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001558370-25-006850 | 20250331 | Stockholders Equity | -2089855.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001558370-25-006850 | 20231231 | Stock Issued During Period Value Stock Options Exercised | 298742.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001558370-25-006850 | 20240331 | Net Cash Provided By Used In Operating Activities | -13604966.0000 | USD | 2 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20250331 | Net Income Loss | -6374787.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20240930 | Accumulated Other Comprehensive Income Loss Net Of Tax | -2063267.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20231231 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 803418.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20241231 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 2701931.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20250331 | Assets | 115415420.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20250331 | Assets Current | 115167403.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 91683074.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20240930 | Common Stock Shares Issued | 44388550.0000 | shares | 0 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20250331 | Common Stock Shares Outstanding | 44388550.0000 | shares | 0 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20250331 | Common Stock Value | 279862420.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20240331 | Comprehensive Income Net Of Tax | -14934482.0000 | USD | 2 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20250331 | Comprehensive Income Net Of Tax | -14933306.0000 | USD | 2 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20250331 | Earnings Per Share Basic | -0.3400 | USD | 2 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20250331 | Net Cash Provided By Used In Financing Activities | 0.0000 | USD | 2 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20240930 | Operating Lease Liability Current | 124054.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20240331 | Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | -749.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20240331 | Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans | 33353.0000 | USD | 2 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20250331 | Profit Loss | -14906718.0000 | USD | 2 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20250331 | Retained Earnings Accumulated Deficit | -222910898.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20250331 | Right Of Use Asset Obtained In Exchange For Operating Lease Liability | 0.0000 | USD | 2 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20230930 | Shares Outstanding | 44100838.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001558370-25-006850 | 20240930 | Shares Outstanding | 44388550.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001558370-25-006850 | 20230930 | Stockholders Equity | -179461359.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001558370-25-006850 | 20231231 | Stockholders Equity | -2100274.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001558370-25-006850 | 20231231 | Stockholders Equity | 278511447.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001558370-25-006850 | 20240930 | Stockholders Equity | 54810797.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001558370-25-006850 | 20241231 | Stockholders Equity | -216536111.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001558370-25-006850 | 20240331 | Stock Issued During Period Shares Stock Options Exercised | 199344.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001558370-25-006850 | 20231231 | Stock Issued During Period Value Stock Options Exercised | -135436.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001558370-25-006850 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 1132601.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20240930 | Cash And Cash Equivalents At Carrying Value | 103709537.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20240930 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 103709537.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20250331 | General And Administrative Expense | 8107954.0000 | USD | 2 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20240331 | Increase Decrease In Accounts Payable And Accrued Liabilities | 659459.0000 | USD | 2 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20250331 | Increase Decrease In Prepaid Expense | 237756.0000 | USD | 2 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20240331 | Interest And Other Income | 1489812.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20240331 | Interest And Other Income | 3128601.0000 | USD | 2 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20250331 | Interest And Other Income | 1008776.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20240331 | Net Income Loss | -14953857.0000 | USD | 2 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20240331 | Operating Expenses | 18088121.0000 | USD | 2 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20250331 | Payments To Acquire Short Term Investments | 27407539.0000 | USD | 2 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20240331 | Profit Loss | -14953857.0000 | USD | 2 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20250331 | Research And Development Expense | 8958589.0000 | USD | 2 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20240930 | Short Term Investments | 23050582.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20230930 | Stockholders Equity | 278161537.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001558370-25-006850 | 20240331 | Stockholders Equity | 50305585.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001558370-25-006850 | 20240331 | Stockholders Equity | -194415216.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001558370-25-006850 | 20231231 | Stock Issued During Period Shares Employee Stock Purchase Plans | 14476.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001558370-25-006850 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 44237124.0000 | shares | 1 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 44388550.0000 | shares | 1 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20250331 | Additional Paid In Capital | 58684837.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 1132601.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001558370-25-006850 | 20230930 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 33701912.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 86308345.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20240331 | Comprehensive Income Net Of Tax | -749.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001558370-25-006850 | 20250331 | Comprehensive Income Net Of Tax | -17822.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001558370-25-006850 | 20240331 | Earnings Per Share Basic | -0.2000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20250331 | Earnings Per Share Basic | -0.1400 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20250331 | Increase Decrease In Accounts Payable And Accrued Liabilities | -1588258.0000 | USD | 2 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20240331 | Increase Decrease In Operating Lease Liability | -60677.0000 | USD | 2 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20240331 | Increase Decrease In Prepaid Expense | 608736.0000 | USD | 2 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20250331 | Investment Income Net | 55225.0000 | USD | 2 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20250331 | Net Income Loss | -14906718.0000 | USD | 2 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20250331 | Operating Expenses | 17066543.0000 | USD | 2 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20240930 | Operating Lease Liability Noncurrent | 205206.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20250331 | Operating Lease Right Of Use Asset Amortization Expense | 47454.0000 | USD | 2 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20250331 | Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | -26588.0000 | USD | 2 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20240331 | Proceeds From Stock Options Exercised | 806909.0000 | USD | 2 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20250331 | Proceeds From Stock Options Exercised | 0.0000 | USD | 2 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20240930 | Receivables Net Current | 162973.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20240331 | Research And Development Expense | 6177987.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20231231 | Shares Outstanding | 44163647.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001558370-25-006850 | 20240331 | Stockholders Equity | -2101023.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001558370-25-006850 | 20240331 | Stockholders Equity | 279679513.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001558370-25-006850 | 20240930 | Stockholders Equity | 279862420.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001558370-25-006850 | 20231231 | Stock Issued During Period Shares Stock Options Exercised | 48333.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001558370-25-006850 | 20240331 | Stock Issued During Period Value Stock Options Exercised | 643603.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20240930 | Accounts Payable And Accrued Liabilities Current | 3176973.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20240930 | Additional Paid In Capital | 54810797.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20240930 | Assets | 128112003.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | 57981162.0000 | USD | 2 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20250331 | Common Stock Shares Issued | 44388550.0000 | shares | 0 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20231231 | Comprehensive Income Net Of Tax | -5964322.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001558370-25-006850 | 20240331 | Comprehensive Income Net Of Tax | -8990284.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20240331 | Earnings Per Share Basic | -0.3400 | USD | 2 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20240331 | Foreign Currency Transaction Gain Loss Before Tax | 5663.0000 | USD | 2 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20250331 | Foreign Currency Transaction Gain Loss Before Tax | 4516.0000 | USD | 2 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20250331 | Increase Decrease In Receivables | 822.0000 | USD | 2 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20240331 | Net Cash Provided By Used In Investing Activities | 70741345.0000 | USD | 2 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20240331 | Operating Expenses | 10493489.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20250331 | Operating Expenses | 7381677.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20240331 | Proceeds From Sale Of Short Term Investments | 93032441.0000 | USD | 2 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20250331 | Research And Development Expense | 3484442.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20231231 | Stockholders Equity | 140682939.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20240331 | Stockholders Equity | 133468859.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20250331 | Stockholders Equity | 113546504.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20231231 | Stock Issued During Period Value Employee Stock Purchase Plan | 33353.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20231231 | Stock Issued During Period Value Employee Stock Purchase Plan | -17815.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001558370-25-006850 | 20241231 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 2701931.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001558370-25-006850 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 1172109.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 1172109.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001558370-25-006850 | 20241231 | Comprehensive Income Net Of Tax | -8540697.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20240331 | Earnings Per Share Diluted | -0.2000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20240331 | Earnings Per Share Diluted | -0.3400 | USD | 2 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20250331 | Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 0.0000 | USD | 2 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20250331 | Foreign Currency Transaction Gain Loss Before Tax | -1886.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20240331 | Foreign Currency Transaction Gain Loss Unrealized | 4826.0000 | USD | 2 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20250331 | Foreign Currency Transaction Gain Loss Unrealized | 0.0000 | USD | 2 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20250331 | Liabilities And Stockholders Equity | 115415420.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20250331 | Net Cash Provided By Used In Investing Activities | -4082539.0000 | USD | 2 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20250331 | Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans | 0.0000 | USD | 2 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20250331 | Proceeds From Sale Of Short Term Investments | 23325000.0000 | USD | 2 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20240331 | Right Of Use Asset Obtained In Exchange For Operating Lease Liability | 318144.0000 | USD | 2 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20240331 | Shares Outstanding | 44362991.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001558370-25-006850 | 20250331 | Short Term Investments | 27564067.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20240930 | Stockholders Equity | -2063267.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001558370-25-006850 | 20240930 | Stockholders Equity | -208004180.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001558370-25-006850 | 20241231 | Stockholders Equity | 118767004.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20250331 | Stockholders Equity | 279862420.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001558370-25-006850 | 20231231 | Stock Issued During Period Value Employee Stock Purchase Plan | 51168.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001558370-25-006850 | 20240331 | Stock Issued During Period Value Stock Options Exercised | 1168066.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001558370-25-006850 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 44183013.0000 | shares | 2 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 44388550.0000 | shares | 2 | us-gaap/2024 | |||
| 0001558370-25-006850 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 44183013.0000 | shares | 2 | us-gaap/2024 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| ddate | The end date for the data value, rounded to the nearest month end. |
| qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
| uom | The unit of measure for the value. |
| segments | Tags used to represent axis and member reporting. |
| coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
| value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
| footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
| tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
|---|---|---|---|---|---|---|---|---|
| Stock Issued During Period Value Stock Options Exercised | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, Stock Options Exercised | Value of stock issued as a result of the exercise of stock options. |
| Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Operating Lease Liability Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Current | Present value of lessee's discounted obligation for lease payments from operating lease, classified as current. |
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | us-gaap/2024 | 0 | 0 | monetary | D | D | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | Amount of increase in right-of-use asset obtained in exchange for operating lease liability. |
| Accounts Payable And Accrued Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accounts Payable and Accrued Liabilities, Current | Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits. |
| Comprehensive Income Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. |
| Liabilities | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities | Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. |
| Liabilities And Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
| Proceeds From Stock Options Exercised | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Stock Options Exercised | Amount of cash inflow from exercise of option under share-based payment arrangement. |
| Retained Earnings Accumulated Deficit | us-gaap/2024 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
| Short Term Investments | us-gaap/2024 | 0 | 0 | monetary | I | D | Short-Term Investments | Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current. |
| Additional Paid In Capital | us-gaap/2024 | 0 | 0 | monetary | I | C | Additional Paid in Capital | Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock. |
| Common Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | 0 | 0 | monetary | D | D | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Increase Decrease In Receivables | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Receivables | The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities. |
| Net Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
| Prepaid Expense Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Prepaid Expense, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer. |
| Receivables Net Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Receivables, Net, Current | The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value. |
| Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
| Stock Issued During Period Value Employee Stock Purchase Plan | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, Employee Stock Purchase Plan | Aggregate change in value for stock issued during the period as a result of employee stock purchase plan. |
| Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | |
| Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | I | C | Accumulated Other Comprehensive Income (Loss), Net of Tax | Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source. |
| Assets | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
| Common Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
| Earnings Per Share Diluted | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
| Foreign Currency Transaction Gain Loss Unrealized | us-gaap/2024 | 0 | 0 | monetary | D | C | Unrealized Gain (Loss), Foreign Currency Transaction, before Tax | Amount, before tax, of unrealized gain (loss) from foreign currency transaction. |
| Increase Decrease In Prepaid Expense | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Prepaid Expense | The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods. |
| Operating Lease Right Of Use Asset | us-gaap/2024 | 0 | 0 | monetary | I | D | Operating Lease, Right-of-Use Asset | Amount of lessee's right to use underlying asset under operating lease. |
| Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
| Share Based Compensation | us-gaap/2024 | 0 | 0 | monetary | D | D | Share-Based Payment Arrangement, Noncash Expense | Amount of noncash expense for share-based payment arrangement. |
| Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash and Cash Equivalents, at Carrying Value | Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. |
| Foreign Currency Transaction Gain Loss Before Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Gain (Loss), Foreign Currency Transaction, before Tax | Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction. |
| Proceeds From Sale Of Short Term Investments | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Sale of Short-Term Investments | The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term. |
| Profit Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. |
| Common Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Interest And Other Income | us-gaap/2024 | 0 | 0 | monetary | D | C | Interest and Other Income | The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business). |
| Net Cash Provided By Used In Operating Activities | us-gaap/2024 | 0 | 0 | monetary | D | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | |
| Operating Expenses | us-gaap/2024 | 0 | 0 | monetary | D | D | Operating Expenses | Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. |
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax | Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale. |
| General And Administrative Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | General and Administrative Expense | The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. |
| Research And Development Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Research and Development Expense | Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. |
| Accretion Amortization Of Discounts And Premiums Investments | us-gaap/2024 | 0 | 0 | monetary | D | C | Accretion (Amortization) of Discounts and Premiums, Investments | The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | 0 | 0 | monetary | D | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Increase Decrease In Operating Lease Liability | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Operating Lease Liability | Amount of increase (decrease) in obligation for operating lease. |
| Investment Income Net | us-gaap/2024 | 0 | 0 | monetary | D | C | Investment Income, Net | Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities. |
| Net Cash Provided By Used In Financing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Financing Activities | Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. |
| Operating Lease Right Of Use Asset Amortization Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Operating Lease, Right-of-Use Asset, Periodic Reduction | Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease. |
| Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Shares, Outstanding | Number of shares issued which are neither cancelled nor held in the treasury. | |
| Accretion Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Accretion Expense | Amount recognized for the passage of time, typically for liabilities, that have been discounted to their net present values. Excludes accretion associated with asset retirement obligations. |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2024 | 0 | 0 | monetary | D | C | APIC, Share-Based Payment Arrangement, Increase for Cost Recognition | Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. |
| Earnings Per Share Basic | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
| Increase Decrease In Accounts Payable And Accrued Liabilities | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable and Accrued Liabilities | The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid. |
| Net Cash Provided By Used In Investing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Investing Activities | Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. |
| Stock Issued During Period Shares Employee Stock Purchase Plans | us-gaap/2024 | 0 | 0 | shares | D | Stock Issued During Period, Shares, Employee Stock Purchase Plans | Number of shares issued during the period as a result of an employee stock purchase plan. | |
| Stock Issued During Period Shares Stock Options Exercised | us-gaap/2024 | 0 | 0 | shares | D | Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period | Number of share options (or share units) exercised during the current period. | |
| Deposits Assets Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | D | Deposits Assets, Noncurrent | Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer. |
| Operating Lease Liability Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Noncurrent | Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent. |
| Payments To Acquire Short Term Investments | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments to Acquire Short-Term Investments | The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term. |
| Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Excluding Option Exercised | Amount of cash inflow from issuance of shares under share-based payment arrangement. Excludes option exercised. |
| Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. |
| Field Name | Field Description |
|---|---|
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
| abstract | 1 if the tag is not used to represent a numeric fact. |
| datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
| iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
| crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
| tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
| doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
| adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
|---|---|---|---|---|---|---|---|---|---|
| 0001558370-25-006850 | 2 | 3 | BS | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | Cash and cash equivalents | 0 |
| 0001558370-25-006850 | 2 | 4 | BS | 0 | H | Short Term Investments | us-gaap/2024 | Short-term investments (Note 4) | 0 |
| 0001558370-25-006850 | 2 | 5 | BS | 0 | H | Receivables Net Current | us-gaap/2024 | Receivables | 0 |
| 0001558370-25-006850 | 2 | 6 | BS | 0 | H | Prepaid Expense Current | us-gaap/2024 | Prepaids (Note 5) | 0 |
| 0001558370-25-006850 | 2 | 7 | BS | 0 | H | Assets Current | us-gaap/2024 | Total current assets | 0 |
| 0001558370-25-006850 | 2 | 8 | BS | 0 | H | Deposits Assets Noncurrent | us-gaap/2024 | Deposits | 0 |
| 0001558370-25-006850 | 2 | 9 | BS | 0 | H | Operating Lease Right Of Use Asset | us-gaap/2024 | Operating lease right-of-use asset (Note 7) | 0 |
| 0001558370-25-006850 | 2 | 10 | BS | 0 | H | Assets | us-gaap/2024 | Total assets | 0 |
| 0001558370-25-006850 | 2 | 13 | BS | 0 | H | Accounts Payable And Accrued Liabilities Current | us-gaap/2024 | Accounts payable and accrued liabilities (Note 6) | 0 |
| 0001558370-25-006850 | 2 | 14 | BS | 0 | H | Operating Lease Liability Current | us-gaap/2024 | Current portion of operating lease liability (Note 7) | 0 |
| 0001558370-25-006850 | 2 | 15 | BS | 0 | H | Liabilities Current | us-gaap/2024 | Total current liabilities | 0 |
| 0001558370-25-006850 | 2 | 16 | BS | 0 | H | Operating Lease Liability Noncurrent | us-gaap/2024 | Operating lease liability (Note 7) | 0 |
| 0001558370-25-006850 | 2 | 17 | BS | 0 | H | Liabilities | us-gaap/2024 | Total liabilities | 0 |
| 0001558370-25-006850 | 2 | 19 | BS | 0 | H | Common Stock Value | us-gaap/2024 | Common shares 44,388,550 issued and outstanding (September 30, 2024 - 44,388,550) (Note 8) | 0 |
| 0001558370-25-006850 | 2 | 20 | BS | 0 | H | Additional Paid In Capital | us-gaap/2024 | Additional paid-in capital (Note 8) | 0 |
| 0001558370-25-006850 | 2 | 21 | BS | 0 | H | Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | Accumulated other comprehensive loss | 0 |
| 0001558370-25-006850 | 2 | 22 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2024 | Accumulated deficit | 0 |
| 0001558370-25-006850 | 2 | 23 | BS | 0 | H | Stockholders Equity | us-gaap/2024 | Total stockholders equity | 0 |
| 0001558370-25-006850 | 2 | 24 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2024 | Total liabilities and shareholders' equity | 0 |
| 0001558370-25-006850 | 3 | 1 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2024 | Common stock, shares issued | 0 |
| 0001558370-25-006850 | 3 | 2 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2024 | Common stock, shares outstanding | 0 |
| 0001558370-25-006850 | 4 | 2 | IS | 0 | H | Research And Development Expense | us-gaap/2024 | Research and development | 0 |
| 0001558370-25-006850 | 4 | 3 | IS | 0 | H | General And Administrative Expense | us-gaap/2024 | General and administration | 0 |
| 0001558370-25-006850 | 4 | 4 | IS | 0 | H | Operating Expenses | us-gaap/2024 | Total operating expenses | 1 |
| 0001558370-25-006850 | 4 | 5 | IS | 0 | H | Foreign Currency Transaction Gain Loss Before Tax | us-gaap/2024 | Foreign exchange | 0 |
| 0001558370-25-006850 | 4 | 6 | IS | 0 | H | Interest And Other Income | us-gaap/2024 | Investment and other income | 0 |
| 0001558370-25-006850 | 4 | 8 | IS | 0 | H | Net Income Loss | us-gaap/2024 | Net loss for the period | 0 |
| 0001558370-25-006850 | 4 | 10 | IS | 0 | H | Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | us-gaap/2024 | Unrealized (loss) gain on short-term investments (Note 4) | 0 |
| 0001558370-25-006850 | 4 | 11 | IS | 0 | H | Comprehensive Income Net Of Tax | us-gaap/2024 | Loss and comprehensive loss for the period | 0 |
| 0001558370-25-006850 | 4 | 13 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2024 | Basic loss per common share (in dollars per share) | 0 |
| 0001558370-25-006850 | 4 | 14 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2024 | Diluted loss per common share (in dollars per share) | 0 |
| 0001558370-25-006850 | 4 | 15 | IS | 0 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | Weighted average number of common shares outstanding - Basic (in shares) | 0 |
| 0001558370-25-006850 | 4 | 16 | IS | 0 | H | Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | Weighted average number of common shares outstanding -Diluted (in shares) | 0 |
| 0001558370-25-006850 | 5 | 2 | CF | 0 | H | Profit Loss | us-gaap/2024 | Net loss for the period | 0 |
| 0001558370-25-006850 | 5 | 4 | CF | 0 | H | Operating Lease Right Of Use Asset Amortization Expense | us-gaap/2024 | Amortization of right-of-use asset | 0 |
| 0001558370-25-006850 | 5 | 5 | CF | 0 | H | Accretion Amortization Of Discounts And Premiums Investments | us-gaap/2024 | Accretion of premiums/discounts on short-term investments, net | 1 |
| 0001558370-25-006850 | 5 | 6 | CF | 0 | H | Accretion Expense | us-gaap/2024 | Accretion of lease liability | 0 |
| 0001558370-25-006850 | 5 | 7 | CF | 0 | H | Investment Income Net | us-gaap/2024 | Accrued investment income | 1 |
| 0001558370-25-006850 | 5 | 8 | CF | 0 | H | Foreign Currency Transaction Gain Loss Unrealized | us-gaap/2024 | Unrealized foreign exchange | 1 |
| 0001558370-25-006850 | 5 | 9 | CF | 0 | H | Share Based Compensation | us-gaap/2024 | Share-based payments | 0 |
| 0001558370-25-006850 | 5 | 11 | CF | 0 | H | Increase Decrease In Receivables | us-gaap/2024 | Receivables | 1 |
| 0001558370-25-006850 | 5 | 12 | CF | 0 | H | Increase Decrease In Prepaid Expense | us-gaap/2024 | Prepaids | 1 |
| 0001558370-25-006850 | 5 | 13 | CF | 0 | H | Increase Decrease In Accounts Payable And Accrued Liabilities | us-gaap/2024 | Accounts payable and accrued liabilities | 0 |
| 0001558370-25-006850 | 5 | 14 | CF | 0 | H | Increase Decrease In Operating Lease Liability | us-gaap/2024 | Operating lease liability | 0 |
| 0001558370-25-006850 | 5 | 15 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2024 | Net cash used in operating activities | 0 |
| 0001558370-25-006850 | 5 | 17 | CF | 0 | H | Payments To Acquire Short Term Investments | us-gaap/2024 | Purchase of short-term investments | 1 |
| 0001558370-25-006850 | 5 | 18 | CF | 0 | H | Proceeds From Sale Of Short Term Investments | us-gaap/2024 | Proceeds from short-term investments sold | 0 |
| 0001558370-25-006850 | 5 | 19 | CF | 0 | H | Net Cash Provided By Used In Investing Activities | us-gaap/2024 | Net cash provided by (used in) investing activities | 0 |
| 0001558370-25-006850 | 5 | 21 | CF | 0 | H | Proceeds From Stock Options Exercised | us-gaap/2024 | Options exercised | 0 |
| 0001558370-25-006850 | 5 | 22 | CF | 0 | H | Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans | us-gaap/2024 | Shares purchased through employee share purchase plan | 0 |
| 0001558370-25-006850 | 5 | 23 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2024 | Net cash provided by financing activities | 0 |
| 0001558370-25-006850 | 5 | 24 | CF | 0 | H | Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | Effect of foreign exchange on cash and cash equivalents | 0 |
| 0001558370-25-006850 | 5 | 25 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | Change in cash and cash equivalents for the period | 0 |
| 0001558370-25-006850 | 5 | 26 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash and cash equivalents, beginning of period | 0 |
| 0001558370-25-006850 | 5 | 27 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash and cash equivalents, end of period | 0 |
| 0001558370-25-006850 | 5 | 29 | CF | 0 | H | Right Of Use Asset Obtained In Exchange For Operating Lease Liability | us-gaap/2024 | Leased assets obtained in exchange for operating lease liabilities | 0 |
| 0001558370-25-006850 | 6 | 9 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Beginning Balance | 0 |
| 0001558370-25-006850 | 6 | 10 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Beginning Balance, in shares | 0 |
| 0001558370-25-006850 | 6 | 11 | EQ | 0 | H | Stock Issued During Period Value Stock Options Exercised | us-gaap/2024 | Options exercised | 0 |
| 0001558370-25-006850 | 6 | 12 | EQ | 0 | H | Stock Issued During Period Shares Stock Options Exercised | us-gaap/2024 | Options exercised, shares | 0 |
| 0001558370-25-006850 | 6 | 13 | EQ | 0 | H | Stock Issued During Period Value Employee Stock Purchase Plan | us-gaap/2024 | Shares issued through employee share purchase plan | 0 |
| 0001558370-25-006850 | 6 | 14 | EQ | 0 | H | Stock Issued During Period Shares Employee Stock Purchase Plans | us-gaap/2024 | Shares issued through employee share purchase plan, shares | 0 |
| 0001558370-25-006850 | 6 | 15 | EQ | 0 | H | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2024 | Share-based payments | 0 |
| 0001558370-25-006850 | 6 | 16 | EQ | 0 | H | Comprehensive Income Net Of Tax | us-gaap/2024 | Loss and comprehensive loss for the period | 0 |
| 0001558370-25-006850 | 6 | 17 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Ending Balance | 0 |
| 0001558370-25-006850 | 6 | 18 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Ending Balance, in shares | 0 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
| line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
| stmt | The financial statement location to which the value of the “report” field pertains. |
| inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
| rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
| tag | The tag chosen by the filer for this line item. |
| version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
| plabel | The text presented on the line item, also known as a “preferred” label. |
| negating | Flag to indicate whether the plabel is negating. |